Cargando…
Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide. Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to diagnose stroke is still a major concern. In addition, therapeutic approaches to combat ischemic stroke are sti...
Autores principales: | Ramiro, Laura, Simats, Alba, García-Berrocoso, Teresa, Montaner, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080077/ https://www.ncbi.nlm.nih.gov/pubmed/30093920 http://dx.doi.org/10.1177/1756286418789340 |
Ejemplares similares
-
Characterization of the rat cerebrospinal fluid proteome following acute cerebral ischemia using an aptamer-based proteomic technology
por: Simats, Alba, et al.
Publicado: (2018) -
Blood Biomarkers in Cardioembolic Stroke
por: García-Berrocoso, Teresa, et al.
Publicado: (2010) -
Evaluation and Characterization of Post-Stroke Lung Damage in a Murine Model of Cerebral Ischemia
por: Faura, Júlia, et al.
Publicado: (2022) -
Cardioembolic Stroke Diagnosis Using Blood Biomarkers
por: Llombart, VÍctor, et al.
Publicado: (2013) -
Blood biomarker changes following therapeutic hypothermia in ischemic stroke
por: Palà, Elena, et al.
Publicado: (2023)